An active agent selected from the group consisting of riboflavin, vitamin A, vitamin C, vitamin D, vitamin E, vitamin K, folic acid, β-carotene, vitamin B1, niacin, vitamin B5, vitamin B6, biotin, vitamin B12, omega-3 fatty acids and combinations thereof, for use in improving intestinal health in an animal, including a human, wherein said improvement comprises or consists of
- i. increasing the concentration of at least one short-chain fatty acid or a salt thereof in the intestine,
- ii. increasing microbiome diversity in the intestine,
- iii. increasing the abundance of a beneficial bacteria in the intestine,
- iv. promoting or increasing the butyrate synthesis pathway in the intestine,
- v. improving the barrier function of the intestine,
- vi. reducing the redox potential of the gut,
- vii. reducing the amount of gas produced in the intestine, and/or
- viii. stimulating intestinal immune responses;
- wherein said use comprises administering to the animal
- a) a formulation comprising an effective dose of the active agent, wherein the active agent is delivered to the large intestine;
- or
- b) a supra physiological dose of an active ingredient so that at least an effective amount of the active ingredient is present in the animal's intestine;
- with the provisos that if niacin is present it is not the sole active ingredient;
- and if riboflavin is present it has an improving effect other than increasing the amount of Faecalibacterium prausnitzii.